ArticleCurrent oncology (Toronto, Ont.)2026
The Use of Artificial Intelligence Chatbots by Newly Diagnosed Cancer Patients: A Descriptive Phenomenological Study.
Article in Current oncology (Toronto, Ont.), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
After a cancer diagnosis, patients experience intense uncertainty and increasingly resort to artificial intelligence chatbots in this process; however, how this use is experienced by patients has not been adequately studied. This study aimed to explore the experiences of adult patients diagnosed with cancer in the last six months using artificial intelligence (AI) chatbots. Using a descriptive phenomenological approach, face-to-face semi-structured interviews were carried out with 20 adults sampled by a criterion-based purposive sampling method in an oncology clinic in Türkiye. The data were analyzed according to Colaizzi's method, and the following four main themes were revealed: artificial intelligence usage purposes, the experience of interacting with AI, the effect of the patient's reflection on the AI experience on the relationship with the treatment team, and evaluation of the use of AI. The participants used chatbots as an intermediate resource during the period of uncertainty between the examination result and clinical explanation; some learned their diagnosis for the first time in this way. However, the relief provided by chatbots was temporary, and trust in chatbot results was constantly tested by the statements of the healthcare professional. As a result, some participants hid their use of chatbots for fear of being judged. AI chatbots served as a complementary source of information, but they did not replace the relationship with the healthcare professional. These findings suggest that healthcare professionals should ask patients about chatbot use without judgment, and that support provided during the post-examination waiting process could be strengthened.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.